Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toremifene for Prevention of Prostate Cancer in Men With High Grade PIN
NCT00106691Phase 3Completed
- Sponsor
- GTx
- Start
- Jan 2005
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of toremifene in prostate cancer (PCa), prostatic intraepithelial neoplasia (PIN), sponsored by GTx. Started Jan 2005; status: completed.
02
Drugs
toremifene
03
Conditions
prostate cancer (PCa)prostatic intraepithelial neoplasia (PIN)
Beyond the preview
Go deeper on NCT00106691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106691.